Literature DB >> 11268441

Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.

S Kikuchi1, M Sato, N Katada, S Sakuramoto, N Kobayashi, H Shimao, Y Sakakibara, A Kakita.   

Abstract

BACKGROUND: The risk of recurrence according to nodal status in patients with node-positive early gastric cancer (EGC) remains unclear and no appropriate treatment approaches have yet been established for such patients.
MATERIALS AND METHODS: The surgical outcome of gastrectomy in combination with lymphadenectomy was examined in a total of 100 patients (54 males and 46 females, ranging in age from 25 to 84 years; average 56.6 years) with EGC and metastasis to lymph nodes. The outcome was assessed with particular reference to the extent of lymph node metastasis.
RESULTS: The 5 and 10-year overall survival rates were 93.5 and 89.8%, respectively. Significant differences in survival were detected when anatomical distribution of lymph node metastasis (p < 0.0001), number of positive nodes (p = 0.0004) and tumor size (p = 0.0085) were examined. In particular, in 73 patients for whom the metastasis was limited to a perigastric node, prognosis was excellent and no recurrence was observed during the follow-up period. On the other hand, 27 patients with metastasis to a lymph node beyond the perigastric region were defined as comprising a high risk group for recurrence among node-positive EGC patients due to their poor prognosis (10-year survival rate, 58.5%).
CONCLUSION: The results of the present study have suggested that radical gastrectomy combined with lymphadenectomy is essential to achieve complete remission in patients with lymph node metastasis restricted to perigastric nodes. For patients with a high risk of recurrence in EGC, whose condition is complicated by lymph node metastasis beyond the perigastric region, care should be taken to prevent recurrence by conducting long-term follow-up even after radical surgery. In order to improve survival, an appropriate protocol for post-operative adjuvant therapy may be needed for patients such as those with advanced gastric cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11268441

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Improving the AJCC/TNM classification for use in early gastric cancer.

Authors:  Paolo G Gobbi; Lara Villano; Donatella Pozzoli; Manuela Bergonzi; Alessandro Vanoli; Francesca Tava; Paolo Dionigi; Gino Roberto Corazza
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

Review 2.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

3.  Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival.

Authors:  Norihiro Yuasa; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2004-04-30       Impact factor: 3.445

4.  Validation of staging systems for gastric cancer.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Shiroh Kikuchi; Natsuya Katada; Nobuyuki Kobayashi; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2008-07-02       Impact factor: 7.370

5.  The superficial elevated and depressed lesion type is an independent factor associated with non-curative endoscopic submucosal dissection for early gastric cancer.

Authors:  Yoshiko Ohara; Nobuyuki Toshikuni; Kazuhiro Matsueda; Hirokazu Mouri; Hiroshi Yamamoto
Journal:  Surg Endosc       Date:  2016-03-02       Impact factor: 4.584

6.  Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival.

Authors:  Shiro Kikuchi; Natsuya Katada; Shinichi Sakuramoto; Nobuyuki Kobayashi; Hitoshi Shimao; Masahiko Watanabe; Yoshiki Hiki
Journal:  Langenbecks Arch Surg       Date:  2004-02-18       Impact factor: 3.445

7.  Laparoscopy-assisted distal gastrectomy for early gastric cancer: experience with 111 consecutive patients.

Authors:  S Sakuramoto; S Kikuchi; S Kuroyama; N Futawatari; N Katada; N Kobayashi; M Watanabe
Journal:  Surg Endosc       Date:  2005-11-09       Impact factor: 3.453

8.  Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer.

Authors:  Bai-Wei Zhao; Yong-Ming Chen; Shan-Shan Jiang; Yin-Bo Chen; Zhi-Wei Zhou; Yuan-Fang Li
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.